Anixa Biosciences
ANIX
ANIX
45 hedge funds and large institutions have $9.95M invested in Anixa Biosciences in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.23% less ownership
Funds ownership: 10.96% → 10.73% (-0.23%)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
45
Holding in Top 10
–
Calls
$151K
Puts
$45K
Top Buyers
| 1 | +$153K | |
| 2 | +$107K | |
| 3 | +$75K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$74K |
| 5 |
LPL Financial
San Diego,
California
|
+$67K |
Top Sellers
| 1 | -$425K | |
| 2 | -$80K | |
| 3 | -$40K | |
| 4 |
Morgan Stanley
New York
|
-$39.3K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$36.1K |